Literature DB >> 12543704

Is it time to change fluoroquinolone breakpoints for Salmonella spp.?

Frank Møller Aarestrup, Camilla Wiuff, Kåre Mølbak, E John Threlfall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12543704      PMCID： PMC151776          DOI： 10.1128/AAC.47.2.827-829.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  22 in total

1.  Reduced susceptibility to quinolones in Salmonella typhi acquired in Europe: a clinical failure of treatment.

Authors:  Zoe Le Lostec; S. Fegueux; P. Jouve; M. Cheron; P. Mornet; A. Boisivon
Journal:  Clin Microbiol Infect       Date:  1997       Impact factor: 8.067

Review 2.  Ciprofloxacin-resistant Salmonella typhi and treatment failure.

Authors:  E J Threlfall; L R Ward; J A Skinner; H R Smith; S Lacey
Journal:  Lancet       Date:  1999-05-08       Impact factor: 79.321

3.  Relapse of multiresistant Salmonella typhi after combined therapy with ciprofloxacin and ceftriaxone.

Authors:  U B Dragsted; P Pedersen
Journal:  Clin Microbiol Infect       Date:  2000-03       Impact factor: 8.067

Review 4.  Mechanisms of quinolone resistance in Salmonella.

Authors:  A Cloeckaert; E Chaslus-Dancla
Journal:  Vet Res       Date:  2001 May-Aug       Impact factor: 3.683

5.  Development of quinolone resistance and multiple antibiotic resistance in Salmonella bovismorbificans in a pancreatic abscess.

Authors:  A P Gibb; C S Lewin; O J Garden
Journal:  J Antimicrob Chemother       Date:  1991-08       Impact factor: 5.790

6.  Selection of multiple resistance in Salmonella enteritidis during treatment with ciprofloxacin.

Authors:  C Pers; P Søgaard; L Pallesen
Journal:  Scand J Infect Dis       Date:  1996

7.  An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104.

Authors:  K Mølbak; D L Baggesen; F M Aarestrup; J M Ebbesen; J Engberg; K Frydendahl; P Gerner-Smidt; A M Petersen; H C Wegener
Journal:  N Engl J Med       Date:  1999-11-04       Impact factor: 91.245

8.  Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment.

Authors:  J Wain; N T Hoa; N T Chinh; H Vinh; M J Everett; T S Diep; N P Day; T Solomon; N J White; L J Piddock; C M Parry
Journal:  Clin Infect Dis       Date:  1997-12       Impact factor: 9.079

9.  Resistance to ciprofloxacin in non-typhoidal salmonellas from humans in England and Wales-the current situation.

Authors:  E. John Threlfall; Linda R. Ward; Bernard Rowe
Journal:  Clin Microbiol Infect       Date:  1999-03       Impact factor: 8.067

10.  Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996-1999.

Authors:  Daniel W Isenbarger; Charles W Hoge; Apichai Srijan; Chittima Pitarangsi; Niyada Vithayasai; Ladaporn Bodhidatta; Kimberly W Hickey; Phung Dac Cam
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883
View more
  52 in total

1.  Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica.

Authors:  Deborah J Eaves; Luke Randall; Douglas T Gray; Antony Buckley; Martin J Woodward; Allan P White; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

2.  Antimicrobial resistance in Salmonella spp. recovered from patients admitted to six different hospitals in Tehran, Iran from 2007 to 2008.

Authors:  Mercedeh Tajbakhsh; Rene S Hendriksen; Zahra Nochi; Mohammad Reza Zali; Frank M Aarestrup; Lourdes Garcia-Migura
Journal:  Folia Microbiol (Praha)       Date:  2012-02-04       Impact factor: 2.099

Review 3.  Antimicrobial resistance: a global multifaceted phenomenon.

Authors:  Francesca Prestinaci; Patrizio Pezzotti; Annalisa Pantosti
Journal:  Pathog Glob Health       Date:  2015-09-07       Impact factor: 2.894

4.  Comparative study of all Salmonella enterica serovar Enteritidis strains isolated from food and food animals in Greece from 2008 to 2010 with clinical isolates.

Authors:  T Papadopoulos; E Petridou; A Zdragas; G Mandilara; S Nair; T Peters; M Chattaway; E de Pinna; M Passiotou; A Vatopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-10       Impact factor: 3.267

5.  Ciprofloxacin-resistant Salmonella enterica serovar Typhimurium strains are difficult to select in the absence of AcrB and TolC.

Authors:  Vito Ricci; Peter Tzakas; Anthony Buckley; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

6.  Overexpression of RamA, Which Regulates Production of the Multidrug Resistance Efflux Pump AcrAB-TolC, Increases Mutation Rate and Influences Drug Resistance Phenotype.

Authors:  Elizabeth M Grimsey; Natasha Weston; Vito Ricci; Jack W Stone; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

7.  Nalidixic acid-resistant strains of Salmonella showing decreased susceptibility to fluoroquinolones in the midwestern region of the Republic of Ireland due to mutations in the gyrA gene.

Authors:  Michael P Ryan; Colm Dillon; Catherine C Adley
Journal:  J Clin Microbiol       Date:  2011-03-09       Impact factor: 5.948

8.  Emergence of extended-spectrum beta-lactamase (CTX-M-15 and CTX-M-14)-producing nontyphoid Salmonella with reduced susceptibility to ciprofloxacin among food animals and humans in Korea.

Authors:  Migma Dorji Tamang; Hyang-Mi Nam; Tae-Sun Kim; Geum-Chan Jang; Suk-Chan Jung; Suk-Kyung Lim
Journal:  J Clin Microbiol       Date:  2011-05-25       Impact factor: 5.948

9.  Increasing prevalence of quinolone resistance in human nontyphoid Salmonella enterica isolates obtained in Spain from 1981 to 2003.

Authors:  José M Marimón; María Gomáriz; Carmen Zigorraga; Gustavo Cilla; Emilio Pérez-Trallero
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

10.  Alternatives to ciprofloxacin use for enteric Fever, United kingdom.

Authors:  E John Threlfall; Elizabeth de Pinna; Martin Day; Joanne Lawrence; Jane Jones
Journal:  Emerg Infect Dis       Date:  2008-05       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.